{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,10]],"date-time":"2026-11-10T08:22:59Z","timestamp":1794298979171,"version":"4.9.0"},"reference-count":30,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2016,8]]},"abstract":"<jats:p>\n                    The critical involvement of dopamine in cognitive processes has been well established, suggesting that therapies targeting dopamine metabolism may alleviate cognitive dysfunction. Catechol-\n                    <jats:italic toggle=\"yes\">O<\/jats:italic>\n                    -methyl transferase (COMT) is a catecholamine-degrading enzyme, the substrates of which include dopamine, epinephrine, and norepinephrine. The present work illustrates the potential therapeutic efficacy of COMT inhibition in alleviating cognitive impairment. A brain-penetrant COMT inhibitor, tolcapone, was tested in normal and phencyclidine-treated rats and COMT-Val transgenic mice. In a novel object recognition procedure, tolcapone counteracted a 24-h-dependent forgetting of a familiar object as well as phencyclidine-induced recognition deficits in the rats at doses ranging from 7.5 to 30\u2009mg\/kg. In contrast, entacapone, a COMT inhibitor that does not readily cross the blood\u2013brain barrier, failed to show efficacy at doses up to 30\u2009mg\/kg. Tolcapone at a dose of 30\u2009mg\/kg also improved novel object recognition performance in transgenic mice, which showed clear recognition deficits. Complementing earlier studies, our results indicate that central inhibition of COMT positively impacts recognition memory processes and might constitute an appealing treatment for cognitive dysfunction related to neuropsychiatric disorders.\n                  <\/jats:p>","DOI":"10.1097\/fbp.0000000000000208","type":"journal-article","created":{"date-parts":[[2016,2,26]],"date-time":"2016-02-26T03:00:03Z","timestamp":1456455603000},"page":"415-421","source":"Crossref","is-referenced-by-count":23,"title":["Brain catechol-O-methyltransferase (COMT) inhibition by tolcapone counteracts recognition memory deficits in normal and chronic phencyclidine-treated rats and in COMT-Val transgenic mice"],"prefix":"10.1097","volume":"27","author":[{"given":"Eric R.","family":"Detrait","sequence":"first","affiliation":[{"name":"UCB Biopharma s.p.r.l., Neuroscience Therapeutic Area, Chemin du Foriest, B-1420 Braine-l\u2019Alleud, Belgium"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Greg V.","family":"Carr","sequence":"additional","affiliation":[{"name":"Lieber Institute for Brain Development"},{"name":"Clinical Brain Disorders Branch, National Institute of Mental Health, NIH, Bethesda, Maryland, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel R.","family":"Weinberger","sequence":"additional","affiliation":[{"name":"Lieber Institute for Brain Development"},{"name":"Psychiatry"},{"name":"Neurology"},{"name":"Neuroscience, Institute of Genetic Medicine, Johns Hopkins School of Medicine, Baltimore"},{"name":"Clinical Brain Disorders Branch, National Institute of Mental Health, NIH, Bethesda, Maryland, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yves","family":"Lamberty","sequence":"additional","affiliation":[{"name":"UCB Biopharma s.p.r.l., Neuroscience Therapeutic Area, Chemin du Foriest, B-1420 Braine-l\u2019Alleud, Belgium"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-20230914","doi-asserted-by":"crossref","first-page":"535","DOI":"10.2165\/00023210-200721070-00002","article-title":"Treatment of cognitive deficits associated with schizophrenia: potential role of catechol-O-methyltransferase inhibitors","volume":"21","author":"Apud","year":"2007","journal-title":"CNS Drugs"},{"key":"R2-20230914","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1038\/sj.npp.1301227","article-title":"Tolcapone improves cognition and cortical information processing in normal human subjects","volume":"32","author":"Apud","year":"2007","journal-title":"Neuropsychopharmacology"},{"key":"R3-20230914","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1111\/j.1471-4159.1992.tb08907.x","article-title":"Extracellular concentrations of dopamine and metabolites in the rat caudate after oral administration of a novel catechol-O-methyltransferase inhibitor Ro-40-7592","volume":"59","author":"Aquas","year":"1992","journal-title":"J Neurochem"},{"key":"R4-20230914","first-page":"47","article-title":"The role of dopamine in schizophrenia from a neurobiological and evolutionary perspective: old fashioned, but still in vogue","volume":"5","author":"Brisch","year":"2014","journal-title":"Front Psychiatry"},{"key":"R5-20230914","doi-asserted-by":"crossref","first-page":"53","DOI":"10.3389\/fncir.2014.00053","article-title":"New perspectives on catecholaminergic regulation of executive circuits: evidence for independent modulation of prefrontal functions by midbrain dopaminergic and noradrenergic neurons","volume":"8","author":"Chandler","year":"2014","journal-title":"Front Neural Circuits"},{"key":"R6-20230914","doi-asserted-by":"crossref","first-page":"33","DOI":"10.3389\/fncir.2014.00033","article-title":"The role of prefrontal catecholamines in attention and working memory","volume":"8","author":"Clark","year":"2014","journal-title":"Front Neural Circuits"},{"issue":"Suppl 2","key":"R7-20230914","doi-asserted-by":"crossref","first-page":"S11","DOI":"10.1097\/00019052-200312002-00003","article-title":"Dysfunction of the human memory systems: role of the dopaminergic transmission","volume":"16","author":"Dujardin","year":"2003","journal-title":"Curr Opin Neurol"},{"key":"R8-20230914","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1016\/j.biopsych.2011.12.023","article-title":"COMT Val(158)Met genotype determines the direction of cognitive effects produced by catechol-O-methyltransferase inhibition","volume":"71","author":"Farrell","year":"2012","journal-title":"Biol Psychiatry"},{"key":"R10-20230914","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1007\/BF01285556","article-title":"Cognitive improvement during Tolcapone treatment in Parkinson\u2019s disease","volume":"104","author":"Gasparini","year":"1997","journal-title":"J Neural Transm"},{"key":"R11-20230914","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.bbr.2012.09.030","article-title":"D(1) receptor agonists reverse the subchronic phencyclidine (PCP)-induced novel object recognition (NOR) deficit in female rats","volume":"238","author":"Horiguchi","year":"2013","journal-title":"Behav Brain Res"},{"key":"R12-20230914","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/B978-0-12-381326-8.00009-0","article-title":"Problems with the present inhibitors and a relevance of new and improved COMT inhibitors in Parkinson\u2019s disease","volume":"95","author":"Kaakkola","year":"2010","journal-title":"Int Rev Neurobiol"},{"key":"R13-20230914","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/S0166-4328(96)02242-5","article-title":"Effects of selective catechol-O-methyltransferase inhibitors on single-trial passive avoidance retention in male rats","volume":"86","author":"Khromova","year":"1997","journal-title":"Behav Brain Res"},{"key":"R14-20230914","doi-asserted-by":"crossref","first-page":"1561","DOI":"10.1177\/0269881112454228","article-title":"Modulation of hippocampal dopamine metabolism and hippocampal-dependent cognitive function by catechol-O-methyltransferase inhibition","volume":"26","author":"Laatikainen","year":"2012","journal-title":"J Psychopharmacol"},{"key":"R15-20230914","doi-asserted-by":"crossref","first-page":"e61839","DOI":"10.1371\/journal.pone.0061839","article-title":"Sexually dimorphic effects of catechol-(O)-methyltransferase (COMT) inhibition on dopamine metabolism in multiple brain regions","volume":"8","author":"Laatikainen","year":"2013","journal-title":"Plos One"},{"key":"R16-20230914","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1007\/s00213-008-1342-1","article-title":"Tolcapone enhances food-evoked dopamine efflux and executive memory processes mediated by the rat prefrontal cortex","volume":"202","author":"Lapish","year":"2009","journal-title":"Psychopharmacology (Berl)"},{"key":"R17-20230914","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1002\/cne.1092","article-title":"Dopamine transporter immunoreactivity in monkey cerebral cortex: regional, laminar, and ultrastructural localization","volume":"432","author":"Lewis","year":"2001","journal-title":"J Comp Neurol"},{"key":"R18-20230914","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/S0166-4328(97)80989-8","article-title":"Catechol-O-methyltransferase inhibitor tolcapone has minor influence on performance in experimental memory models in rats","volume":"82","author":"Liljequist","year":"1997","journal-title":"Behav Brain Res"},{"key":"R19-20230914","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1007\/s00213-011-2536-5","article-title":"Spontaneous object recognition and its relevance to schizophrenia: a review of findings from pharmacological, genetic, lesion and developmental rodent models","volume":"220","author":"Lyon","year":"2012","journal-title":"Psychopharmacology (Berl)"},{"key":"R20-20230914","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1016\/j.euroneuro.2009.01.009","article-title":"D(1)-like receptor activation improves PCP-induced cognitive deficits in animal models: implications for mechanisms of improved cognitive function in schizophrenia","volume":"19","author":"McLean","year":"2009","journal-title":"Eur Neuropsychopharmacol"},{"key":"R21-20230914","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1038\/nrd3628","article-title":"Cognitive dysfunction in psychiatric disorders: characteristics, causes and the quest for improved therapy","volume":"11","author":"Millan","year":"2010","journal-title":"Nat Rev Drug Discov"},{"key":"R22-20230914","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.coph.2004.08.008","article-title":"PCP: from pharmacology to modelling schizophrenia","volume":"5","author":"Morris","year":"2005","journal-title":"Curr Opin Pharmacol"},{"key":"R23-20230914","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/S1353-8020(02)00016-0","article-title":"Effect of peripheral and central catechol-O- methyltransferase inhibition on striatal extracellular levels of dopamine: a microdialysis study in freely moving rats","volume":"9","author":"Napolitano","year":"2003","journal-title":"Parkinsonism Relat Disord"},{"issue":"Suppl 2","key":"R24-20230914","doi-asserted-by":"crossref","first-page":"25","DOI":"10.4088\/JCP.13065su1.06","article-title":"The early longitudinal course of cognitive deficits in schizophrenia","volume":"75","author":"Nuechterlein","year":"2014","journal-title":"J Clin Psychiatry"},{"key":"R25-20230914","doi-asserted-by":"crossref","first-page":"8709","DOI":"10.1523\/JNEUROSCI.2077-08.2008","article-title":"Genetic dissection of the role of catechol-O-methyltransferase in cognition and stress reactivity in mice","volume":"28","author":"Papaleo","year":"2008","journal-title":"J Neurosci"},{"key":"R26-20230914","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.neures.2010.10.001","article-title":"Sub-optimal performance in the 5-choice serial reaction time task in rats was sensitive to methylphenidate, atomoxetine and d-amphetamine, but unaffected by the COMT inhibitor tolcapone","volume":"69","author":"Paterson","year":"2011","journal-title":"Neurosci Res"},{"issue":"Suppl 1","key":"R27-20230914","first-page":"S465","article-title":"Modelling prefrontal cortex deficits in schizophrenia: implications for treatment","volume":"153","author":"Pratt","year":"2008","journal-title":"Br J Pharmacol"},{"key":"R28-20230914","doi-asserted-by":"crossref","first-page":"146","DOI":"10.3389\/fpsyt.2010.00146","article-title":"Translational aspects of the novel object recognition task in rats abstinent following sub-chronic treatment with phencyclidine (PCP): effects of modafinil and relevance to cognitive deficits in schizophrenia","volume":"1","author":"Redrobe","year":"2010","journal-title":"Front Psychiatry"},{"key":"R29-20230914","doi-asserted-by":"crossref","first-page":"1823","DOI":"10.1038\/npp.2014.29","article-title":"Generation and characterization of humanized mice carrying COMT158 Met\/Val alleles","volume":"39","author":"Risbrough","year":"2014","journal-title":"Neuropsychopharmacology"},{"key":"R30-20230914","doi-asserted-by":"crossref","first-page":"209","DOI":"10.2174\/187152712800672481","article-title":"COMT as a drug target for cognitive functions and dysfunctions","volume":"11","author":"Scheggia","year":"2012","journal-title":"CNS Neurol Disord Drug Targets"},{"key":"R32-20230914","doi-asserted-by":"crossref","first-page":"5331","DOI":"10.1523\/JNEUROSCI.1124-04.2004","article-title":"Catechol-O-methyltransferase inhibition improves set-shifting performance and elevates stimulated dopamine release in the rat prefrontal cortex","volume":"24","author":"Tunbridge","year":"2004","journal-title":"J Neurosci"}],"container-title":["Behavioural Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/00008877-201608000-00002","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,14]],"date-time":"2023-09-14T20:03:39Z","timestamp":1694721819000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00008877-201608000-00002"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,8]]},"references-count":30,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2016]]}},"URL":"https:\/\/doi.org\/10.1097\/fbp.0000000000000208","relation":{},"ISSN":["0955-8810"],"issn-type":[{"value":"0955-8810","type":"print"}],"subject":[],"published":{"date-parts":[[2016,8]]}}}